Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03066219
PHASE2

Safety and Efficacy of BRM421 for Dry Eye Syndrome

Sponsor: BRIM Biotechnology Inc.

View on ClinicalTrials.gov

Summary

The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Official title: A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

157

Start Date

2017-02-07

Completion Date

2017-06-28

Last Updated

2026-05-01

Healthy Volunteers

No

Interventions

DRUG

BRM421

0.03%(w/v) BRIM421 ophthalmic solution

DRUG

Placebo

vehicle ophthalmic drops

Locations (2)

Central Maine Eye Care

Lewiston, Maine, United States

Andover Eye Associates

Andover, Massachusetts, United States